Company Filing History:
Years Active: 2000
Title: Rachel Denise Kimmich: Innovator in Biochemical Research
Introduction
Rachel Denise Kimmich is a notable inventor based in Carlsbad, California. She has made significant contributions to the field of biochemical research, particularly in the development of inhibitors for key metabolic enzymes. Her work has implications for various therapeutic applications.
Latest Patents
Rachel holds a patent for "Piperazines as inhibitors of fructose-1,6-bisphosphatase (FBPase)." This patent includes compounds of formula A, where R¹ is aralkyl or cycloalkyl, and R² is cycloalkylmethyl, alkyl, or aralkyl. She has 1 patent to her name, showcasing her innovative approach to biochemical challenges.
Career Highlights
Rachel is currently employed at Ontogen Corporation, where she continues to advance her research in the biochemical sector. Her work at Ontogen has positioned her as a key player in the development of new therapeutic strategies.
Collaborations
Throughout her career, Rachel has collaborated with esteemed colleagues, including Adnan M Mjalli and James Christopher Mason. These partnerships have enriched her research and expanded the impact of her innovations.
Conclusion
Rachel Denise Kimmich exemplifies the spirit of innovation in the field of biochemical research. Her contributions, particularly in the development of enzyme inhibitors, highlight her role as a leading inventor in her domain.